The FDA is seeking advice this week from two of its advisory committees on how manufacturers of a major group of asthma drugs should study their potential risks.
major groupFDA Panels to Advise on LABA Study DesignsMedPage Today Allergy & Immunology Tue, 03/09/2010 - 15:39
|
